Early Stage Clinical Trial of Ginger (Zingiber officinale) as an Add-on Antiepileptic Therapy in Children with Generalized Epilepsies

المؤلفون

  • Abdel Moneim A Eisa Department of Pharmacology, Faculty of Pharmacy, University of Gezira
  • Hayder E Babiker Department of paediatrics, Faculty of Medicine, University of Gezira
  • Imad Eldin M Taj Eldin Department of Pharmacology, Faculty of Pharmacy, University of Gezira
  • Enas M El Tahir Department of pharmaceutical chemistry, Faculty of Pharmacy, University of Gezira
  • Elhadi M Mohamed Ahmed Department of pharmacognosy, Faculty of Pharmacy, University of Gazira

DOI:

https://doi.org/10.53332/kjps.v1i1.38

الكلمات المفتاحية:

Ginger، Epilepsy، Add-on antiepileptic، Clinical trials

الملخص

Epilepsy is a disorder of the brain characterized by the generation of epileptic seizures. Botanicals and herbal materials including some parts from plants are prepared and taken in many ways for treatment of children ill with epilepsy. Conventional

التنزيلات

منشور

2021-08-11

إصدار

مجلد 1 عدد 1 (2020): khartoum Journal of Pharmaceutical Sciences

القسم

Articles

كيفية الاقتباس

Early Stage Clinical Trial of Ginger (Zingiber officinale) as an Add-on Antiepileptic Therapy in Children with Generalized Epilepsies. (2021). Khartoum Journal of Pharmaceutical Sciences, 1(1). https://doi.org/10.53332/kjps.v1i1.38